SHORT MINI FUTURE WARRANT - MERCK & CO. | Real-time BOERSE MUENCHEN 12:27:00 2024-05-23 pm EDT | ||
| 2.42 EUR | -0.41% |
|
| Current month | -8.30% | ||
| 1 month | -14.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 2.42 | -0.41% |
| 24-05-22 | 2.43 | -2.02% |
| 24-05-21 | 2.48 | +3.77% |
| 24-05-20 | 2.39 | -2.05% |
| 24-05-17 | 2.44 | 0.00% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 12:27 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG6CJ0 |
| ISIN | DE000GG6CJ00 |
| Date issued | 2024-04-02 |
| Strike | 157.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.43 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.07 € |
|---|---|
| Lowest since issue | 2.32 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.1
USD
Average target price
141.6
USD
Spread / Average Target
+8.04%
- Stock Market
- Certificates
- Certificat
